[144] Vistra Corp. SEC Filing

Rhea-AI Filing Summary

Vistra Corp. (VST) Form 144 notifies the proposed sale of 21,360 common shares through Fidelity Brokerage Services on the NYSE, with an aggregate market value of $4,490,151.57 based on the filing. The shares were recorded as acquired by exercise of options (grants dated 10/11/2016 and 04/09/2018) and are to be sold for cash on 09/23/2025. The filing lists total shares outstanding as 338,820,324. The filer, identified in historical sales as James A. Burke, also reported multiple share sales in the prior two weeks (09/10/2025–09/22/2025) with gross proceeds shown for each transaction. By signing, the seller represents there is no undisclosed material adverse information and discloses reliance, if any, on a trading plan or Rule 10b5-1 instructions.

Positive

• Transparent disclosure of the proposed sale with broker, share count, aggregate market value, and sale date
• Source of shares disclosed as options granted in 2016 and 2018, indicating vested equity monetization
• Prior sales itemized for the preceding two weeks, improving traceability of insider transactions

Negative

• Insider selling activity totaling 21,360 shares (~$4.49M) could be interpreted by some investors as liquidity-taking
• Multiple recent sales (09/10/2025–09/22/2025) by the same individual may attract market attention

Insights

Securities Analyst

TL;DR Routine insider sale of option-derived shares totaling 21,360 shares for ~$4.49M; disclosure aligns with Rule 144 requirements.

The filing documents a planned sale of common stock that was acquired via option exercises, with the transaction routed through Fidelity and scheduled on the NYSE for 09/23/2025. The seller has executed a series of sales in the prior two weeks, with itemized dates and gross proceeds, which provides transparency into recent insider liquidity. This notice is procedural and compliant with Rule 144; it does not by itself disclose company operational or financial changes.

Corporate Governance Expert

TL;DR Filing shows consistent insider disclosure and option exercise monetization, important for governance transparency.

The Form 144 lists the source of the shares as option grants from 2016 and 2018 and confirms cash payment at sale, indicating monetization of vested equity rather than issuance or transfer. The seller affirms absence of material nonpublic information and documents prior recent sales, which helps stakeholders assess insider activity patterns. There is no indication in the filing of any governance irregularity; it is a standard disclosure of insider selling activity.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	21360	4490151.57	338820324	09/23/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/23/2025	Options Granted - 10/11/2016	Issuer			19200	09/23/2025	Cash
Common	09/23/2025	Options Granted - 04/09/2018	Issuer			2160	09/23/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
James A. Burke 6555 Sierra Drive Irving TX 75039	Common	09/10/2025	19592	3933635.75
James A. Burke 6555 Sierra Drive Irving TX 75039	Common	09/11/2025	43074	8991625.77
James A. Burke 6555 Sierra Drive Irving TX 75039	Common	09/12/2025	21374	4335603.72
James A. Burke 6555 Sierra Drive Irving TX 75039	Common	09/15/2025	21362	4481773.62
James A. Burke 6555 Sierra Drive Irving TX 75039	Common	09/16/2025	21358	4565882.26
James A. Burke 6555 Sierra Drive Irving TX 75039	Common	09/17/2025	21361	4540506.03
James A. Burke 6555 Sierra Drive Irving TX 75039	Common	09/18/2025	21366	4554708.26
James A. Burke 6555 Sierra Drive Irving TX 75039	Common	09/19/2025	21360	4517570.62
James A. Burke 6555 Sierra Drive Irving TX 75039	Common	09/22/2025	21362	4503715.06

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filed for VST report?

It reports a proposed sale of 21,360 common shares through Fidelity on the NYSE with an aggregate market value of $4,490,151.57, dated 09/23/2025.

Who is the seller named in the filing for VST?

The filing identifies prior seller activity by James A. Burke at the address shown and lists multiple sales between 09/10/2025 and 09/22/2025.

How were the shares being sold acquired?

The shares were acquired via option grants (granted 10/11/2016 and 04/09/2018) and are to be sold for cash on the stated sale date.

Does the filing indicate any undisclosed material information?

By signing the Form 144, the seller represents they do not know of any material adverse information about the issuer that has not been publicly disclosed.

Where will the proposed sale be executed?

The proposed sale is to be executed on the NYSE through Fidelity Brokerage Services LLC.